limestone has been researched along with sorafenib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kini, S; Panda, D; Poojari, R; Srivastava, R | 1 |
| Chen, Y; He, C; Lee, RJ; Li, M; Lu, Y; Wang, Y; Xiang, G; Yang, T; You, J; Zhang, X; Zhao, P | 1 |
2 other study(ies) available for limestone and sorafenib
| Article | Year |
|---|---|
Intracellular interactions of electrostatically mediated layer-by-layer assembled polyelectrolytes based sorafenib nanoparticles in oral cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Calcium Carbonate; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dextran Sulfate; DNA Fragmentation; Drug Carriers; Drug Compounding; Drug Liberation; Epithelial Cells; Humans; Kinetics; Mouth Mucosa; Nanoparticles; Niacinamide; Peptides; Phenylurea Compounds; Polyelectrolytes; Protein Kinase Inhibitors; Sorafenib; Static Electricity | 2016 |
Enhancing anti-tumor efficiency in hepatocellular carcinoma through the autophagy inhibition by miR-375/sorafenib in lipid-coated calcium carbonate nanoparticles.
Topics: Animals; Calcium Carbonate; Carcinoma, Hepatocellular; Coated Materials, Biocompatible; Delayed-Action Preparations; Hep G2 Cells; Humans; Lipids; Liver Neoplasms; Mice; Mice, Nude; MicroRNAs; Nanoparticles; Sorafenib; Xenograft Model Antitumor Assays | 2018 |